海爾生物(688139.SH)將於10月25日上市
格隆匯10月23日丨海爾生物(688139.SH)發佈首次公開發行股票科創板上市公告書,發行數量7926.794萬股,無老股轉讓;發行價為15.53元/股,將於2019年10月25日在上海證券交易所上市。
2019年1-9月,公司主營業務穩步發展。2019年1-9月,公司實現營業收入7.28億元,同比增加17.80%;公司歸屬於母公司股東的淨利潤和扣除非經常性損益後的歸屬於母公司股東的淨利潤分別為1.33億元和1.18億元,分別較去年同期增加78.70%和253.53%。2018年1-9月,公司歸屬於母公司股東的淨利潤和扣除非經常性損益後的歸屬於母公司股東的淨利潤分別為7461.83萬元和3345.86萬元,主要是由於去年同期因股權激勵確認相關費用4592.97萬元。
剔除2018年1-9月股權激勵費用影響後:2019年1-9月歸屬於母公司股東的淨利潤較2018年同期增長10.61%;扣除非經常性損益後歸屬於母公司股東的淨利潤較2018年同期增長3889.65萬元,增幅為49.00%,去年同期理財產品投資收益等非經常性損益金額較大,而去年同期因借入短期銀行借款,財務費用達到894.81萬元,2019年1月償還55,430萬元銀行借款後,發行人2019年1-9月財務費用同比減少2734.28萬元。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.